Now keep in mind, there are currently no treatments options that are available today that can help reduce the negative side effects from a TBI, like chronic pain, anxiety, depressive behaviors, and even impaired social interactions (Belardo, et al., 2019). This leaves the door open for testing alternative treatments to help those that have suffered from a brain injury since there is currently nothing out there that was shown successful, which I can’t emphasize enough.
Now this is where it gets interesting…
According to Frontiers in Pharmacology, a peer reviewed research database, Oral applications of CBD were shown to prevent painful touch that develops after a mild traumatic brain injury, prevent neurological dysfunctions, “restore” behavioral changes, and help balance the cortical biochemical changes due to CBD’s ability to create and maintain homeostasis (Belardo, et al., 2019).
Just to reiterate, there is no effective treatment available.
How could it get any better? It does!! Check this out…
Frontiers of Pharmacology also stated in another study that CB1 and CB2 (the receptors that CBD acts on) are responsible for controlling (modulating) cell death, excitotoxicity (excessive exposure to glutamate), neuroinflammation, cerebral vascular breakdown, cell building, and remodeling, which could be CBD is so effective (Schurman, 2017). Say what?? Absolutely breathtaking.
Now why am I so adamant and passionate about getting this information out to the public? These studies were from 2017 and 2019. Now tell me, what patients that had a TBI since 2017 were recommended CBD to help improve their condition? There is a flaw in the system and it's our job to bring awareness to this problem so we can demand a change and help improve people's lives.
*This information is for educational purposes only.
Belardo, C., Iannotta, M., Boccella, S., Rubino, R. C., Ricciardi, F., Infantino, R., Pieretti, G., Stella, L., Paino, S., Marabese, I., Maisto, R., Luongo, L., Maione, S., & Guida, F. (2019). Oral Cannabidiol Prevents Allodynia and Neurological Dysfunctions in a Mouse Model of Mild Traumatic Brain Injury. Frontiers in pharmacology, 10, 352. https://doi.org/10.3389/fphar.2019.00352
Schurman, L. D., & Lichtman, A. H. (2017). Endocannabinoids: A Promising Impact for Traumatic Brain Injury. Frontiers in pharmacology, 8, 69. https://doi.org/10.3389/fphar.2017.00069